CEO Phil Wilding will be talking to us on Monday about the Pathway to Production..It’s his introduction to shareholders and well worth watching.It will be interesting to hear his comments about the recently completed drilling campaign and the first phase of the new 35,000m extensional and exploration drilling.Next year will be the most exciting in the project’s history with up to 4 AC and DD drilling rigs delivering a rich news flow.A highlight will be the MRE update in Q2.Will the new MRE have a large enough oxide gold component to support a Stage 1 oxide gold processing re-start followed by a Stage 2 UG refractory operation?Around the end of Q3 but perhaps earlier, we see the DFS with the new Reserve.1m oz of gold in the mining plan is likely, and it could be a lot more.The life of mine will likely be 10 years in the DFS, but more exploration will extend that.Youanmi has potential way beyond 1m ozs of gold.In 2025 we find out what Nathan has delivered for us in the Process plant design and cost.Expect a higher gold recovery than in the PFS.Unlike many other developing mines, the environmental and other approvals are a done deal.There are many other significant milestones on page 15 of the presentation.There are also prospects of new discoveries, such as at the undrilled corridor between Paddy’s and Pollard.Watch Currens drilling as well.There is a new lode to be drilled that could be another Penny.2025 will be a very busy and transformational year for Rox.IMO the market valuation of the company in 12 months will double.
- Forums
- ASX - By Stock
- RXL
- Ann: Investor Presentation - Pathway to Production
RXL
rox resources limited
Add to My Watchlist
1.75%
!
29.0¢

Ann: Investor Presentation - Pathway to Production, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
29.0¢ |
Change
0.005(1.75%) |
Mkt cap ! $212.4M |
Open | High | Low | Value | Volume |
28.5¢ | 29.5¢ | 28.5¢ | $783.8K | 2.745M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | 28.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.0¢ | 87999 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | 0.285 |
1 | 85506 | 0.280 |
2 | 52000 | 0.275 |
12 | 315190 | 0.270 |
3 | 243500 | 0.265 |
Price($) | Vol. | No. |
---|---|---|
0.290 | 27999 | 1 |
0.295 | 106291 | 2 |
0.300 | 128300 | 4 |
0.305 | 144436 | 3 |
0.310 | 60003 | 2 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
RXL (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online